Article
High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Oct 2018
Abozeid Mai, Alsebaey Ayman, Abdelsameea Eman, Othman Warda, Elhelbawy Mostafa, Rgab Amr, Elfayomy Marwa, Abdel-Ghafar Tamer Samir, Abdelkareem Mervat, Sabry Alyaa, Fekry Marwa, Shebl Nashwa, Rewisha Eman, Waked Imam
Abstract excerpt
BACKGROUND: Direct acting antivirals (DAAs) are highly effective for treatment of hepatitis C (HCV) but brand products are priced beyond the means of most low and middle income countries (LMICs). Although a few DAAs are offered at reduced prices in access programs, they are still beyond affordability in limited resource settings with a large HCV infected population. Cheap generics might fill this economic need,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.